Company Stock Price of Teladoc, Inc. (TDOC) Increases 11.67%

Teladoc, Inc. stock performance trend indicates that the stock price has rallied 39.17% in the past 12 Weeks , but analyzing the 6 month charts for the stock , the price continues to stay positive and keep the rally at 28.07% . Looking at the past 52 week period, the stock price is up at 109.19% . Relative price strength is a important factor used by wealth management firms while investing in stocks because the indicator compares the stock performance with the overall market. The relative price strength of Teladoc, Inc. has a positive value of 64.61 compared to overall market.Teladoc, Inc. is having a Relative Strength Index of 67.54 which indicates the stock is not yet over sold or over bought based on the technical indicators.

Teladoc, Inc. (NYSE:TDOC) has climbed 11.67% in the past week and advanced 13.01% in the last 4 weeks. In the past week, the company has outperformed the S&P 500 by 11.4% and the outperformance has advanced to 11.73% for the last 4 weeks period.

For the current week, the company shares have a recommendation consensus of Buy. Teladoc, Inc. (NYSE:TDOC) : On Friday heightened volatility was witnessed in Teladoc, Inc. (NYSE:TDOC) which led to swings in the share price. The stock opened for trading at $22.5 and hit $23.65 on the upside , eventually ending the session at $23.45, with a gain of 5.39% or 1.2 points. The heightened volatility saw the trading volume jump to 1,398,816 shares. The 52-week high of the share price is $23.75 and the company has a market cap of $1,272 million. The 52-week low of the share price is at $9.08 .

Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Teladoc Inc was Initiated by Robert W. Baird on Mar 17, 2017 to Outperform, Price Target of the shares are set at $27.Company shares were Reiterated by Chardan Capital Markets on Mar 2, 2017 to Buy, Raises Price Target to $ 28 from a previous price target of $24 .

Company has reported several Insider transactions to the SEC, on Jan 30, 2017, Mark Hirschhorn (Executive VP, COO and CFO) sold 900 shares at 20.00 per share price.On Jan 26, 2017, Jason N Gorevic (President & CEO) sold 100,000 shares at 15.79 per share price.On Jan 23, 2017, Michael H. King (Chief Sales Officer) sold 5,000 shares at 19.00 per share price.

Teladoc Inc Last issued its quarterly earnings results on Mar 1, 2017. The company reported $-0.31 EPS for the quarter, beating the analyst consensus estimate by $ 0.04. Analyst had a consensus of $-0.35. The company had revenue of $37.40 million for the quarter, compared to analysts expectations of $36.72 million. The companys revenue was up 65.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.39 EPS.

Teladoc, Inc. is a telehealth company. The company offers telehealth services via mobile devices, internet, video and phone to clients primarily in the United States. Its solution connects consumers with physicians and behavioral health professionals to treat upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation. Teladoc, Inc. is based in Dallas, Texas.


Leave a Reply

Your email address will not be published. Required fields are marked *